Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in the United States. It is testing iloperidone Depot for Schizophrenia.
Multiple locations, including GlendaleThis study is completed in the United States. It is testing lumateperone for schizophrenia.
Multiple locations, including HollywoodThis study is completed in the United States. It is testing Lumateperone Long-Acting Injectable Formulations for schizophrenia.
Multiple locations, including Los AlamitosThis study was terminated in the United States. It is testing Multiple Rising Doses of TAK-137 for ADHD.
In MarltonThis study is completed in Australia. It focuses on Addiction.
In AdelaideThis study is completed in the United States. It is testing OMS643762 for schizophrenia.
In Long BeachThis study is completed in the United States. It is testing Single Doses of APN1125 for Schizophrenia.
In GlendaleThis study is completed in the United States. It focuses on Schizophrenia.
Multiple locations, including Long BeachThis study is completed in the United States. It is testing elpipodect for schizophrenia.
Multiple locations, including RogersThis study is completed in the United States. It is testing SPD489 for ADHD.
Multiple locations, including Newport BeachThis study is completed in the United States. It focuses on Schizophrenia.
In Garden GroveThis study is completed in the United States. It focuses on ADHD.
In Kansas CityHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.